Nimbus Therapeutics
Nimbus Therapeutics receives $200 million payment from Gilead
November 2, 2016Research and Development Gilead Sciences, Nimbus Therapeutics, nash
Nimbus Therapeutics only signed a deal with Gilead Sciences back in April of this year and yet have already received …
Gilead to buy Nimbus Therapeutics’ unit, trial drug for up to $1.2 billion
April 5, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gilead Sciences, M&A, MA, Nimbus Apollo, Nimbus Therapeutics, merger and acquisitions
Gilead Sciences (Nasdaq: GILD) has agreed to buy a unit of biotechnology firm Nimbus Therapeutics and its trial drug to …
